Speaker illustration

Doctor Satoshi Yasuda

National Cerebral and Cardiovascular Center, Suita (Japan)

Member of:

European Society of Cardiology

EDUCATION 1987 M.D. Tohoku University School of Medicine 2000 Ph.D. Tohoku University School of Medicine PROFESSIONAL EXPERIENCE 2006 – 2007 Assistant Professor and Chief of Coronary Care Unit Tohoku University Hospital Department of Cardiovascular Internal Medicine Sendai, Miyagi, Japan 2007 – 2011 Associate Professor in Cardiovascular Medicine Tohoku University School of Medicine Sendai, Miyagi, Japan 2011 – 2016, Jan Chairman National Cerebral and Cardiovascular Center Department of Cardiovascular Medicine Osaka, Japan 2016. Feb – 2020.Jul Deputy Director General National Cerebral and Cardiovascular Center Department of Cardiovascular Medicine Osaka, Japan 2020. Aug – present Professor and Chairman Tohoku University Graduate School of Medicine Department of Cardiovascular Medicine Sendai, Miyagi, Japan

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.

Event: ESC Asia with APSC & AFC 2020

Topic: European Society of Cardiology

Session: Latest Trials in Asia

Thumbnail

Ethnic differences in the response to anti-thrombotic drugs.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Cardiovascular Disease in Special Populations

Session: Ethnic Differences in Cardiovascular Health

Thumbnail

AFIRE trial: “less is more” lesson from Japan to the world.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Stroke

Session: Racial and Cultural Differences in anti-Thrombotic Therapy between Europe and Asia

Thumbnail

The Japanese AMI registry (JAMIR) and JROAD Registries: How to set up a national registry.

Event: ESC Asia with APSC & AFC

Topic: Acute Myocardial Ischaemia

Session: Regional Registries and Trials

Thumbnail

Intervention - Asian Perspective.

Event: ESC Asia with APSC & AFC

Topic: Other

Session: Highlights of ESC Congress 2019 - II

Thumbnail

AFIRE - Rivaroxaban monotherapy versus combination therapy in patients with atrial fibrillation and stable coronary artery disease

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session: Hot Line Session 3

Thumbnail

This platform is supported by

logo Novo Nordisk